|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| OMIDRIA contract royalty asset, current | ||||||||||||||||||||
| OMIDRIA contract royalty asset | ||||||||||||||||||||
| Receivables | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expense and other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| OMIDRIA contract royalty asset, non-current | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Restricted investments | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| OMIDRIA royalty obligation | ||||||||||||||||||||
| 2029 Notes repurchase obligation, net | ||||||||||||||||||||
| The 2029 Notes | ||||||||||||||||||||
| Total 2029 Notes repurchase obligation, net | ||||||||||||||||||||
| 2026 Notes, net | ||||||||||||||||||||
| Term debt | ||||||||||||||||||||
| Share-settled liability | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| OMIDRIA royalty obligation, non-current | ||||||||||||||||||||
| 2029 Notes, non-current, net | ||||||||||||||||||||
| 2029 Notes embedded derivative, non-current | ||||||||||||||||||||
| The 2029 Notes | ||||||||||||||||||||
| Initial Term Loan | ||||||||||||||||||||
| Total 2029 Notes embedded derivative, non-current | ||||||||||||||||||||
| Term debt, non-current, net | ||||||||||||||||||||
| Lease liabilities, non-current | ||||||||||||||||||||
| Other accrued liabilities, non-current | ||||||||||||||||||||
| Shareholders’ deficit: | ||||||||||||||||||||
| Preferred stock, par value $0.01 per share, 20,000,000 shares authorized; none issued and outstanding at June 30, 2026 and December 31, 2025. | ||||||||||||||||||||
| Common stock, par value $0.01 per share, 150,000,000 shares authorized at June 30, 2026 and December 31, 2025; 72,087,984 and 71,670,791 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders’ deficit | ||||||||||||||||||||
| Total liabilities and shareholders’ deficit | ||||||||||||||||||||
Loading...
